Literature DB >> 10818081

Activation of MAPKs in proximal tubule cells from spontaneously hypertensive and control Wistar-Kyoto rats.

A Parenti1, X L Cui, U Hopfer, M Ziche, J G Douglas.   

Abstract

The aim of this study was to test the hypothesis that differences exist in the activity and/or expression of mitogen-activated protein kinases (MAPKs) between spontaneously hypertensive rats (SHR) and control Wistar-Kyoto rats (WKY) and that these differences may account for the enhanced activity of the Na(+)/H(+) exchanger (NHE) previously observed in the renal proximal tubule of SHR. Therefore, the activities of c-jun N-terminal kinase(1) (JNK(1)), extracellular signal-regulated kinase(1/2) (ERK(1/2)), and p38 were investigated. A reduced amount of ERK(1) and JNK(1) protein was found in renal cortex specimens of SHR as compared with WKY; however, their activities were the same. To study the cellular basis of this difference, immortalized proximal tubule cell lines were grown on Millicell-CM filter inserts where the cell lines organize as polarized monolayers with separate access to apical and basolateral compartments. Although basal JNK(1) and ERK(1/2) activities were not significantly different between WKY and SHR cells, anisomycin stimulated JNK(1) activity in WKY cells more than in SHR cells (eg, at 15 minutes 300% versus 30%, respectively). Similarly, angiotensin II increased JNK(1) and ERK(1/2) activity in a time- and concentration-dependent manner in WKY cells but not in SHR cells. Western blot analyses showed a deficit in JNK(1) and ERK(1) protein in SHR (0.25 and 0.5, respectively, of the levels in WKY cells), although ERK(2) and p38 protein levels were the same. These observations suggest that, although angiotensin II activates MAPKs and MAPKs have been shown to regulate NHE, this regulatory pathway is unlikely to account for the increased activity of NHE in the proximal tubular epithelium of SHR.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818081     DOI: 10.1161/01.hyp.35.5.1160

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

1.  Activation of D4 dopamine receptor decreases angiotensin II type 1 receptor expression in rat renal proximal tubule cells.

Authors:  Ken Chen; Kun Deng; Xiaoyan Wang; Zhen Wang; Shuo Zheng; Hongmei Ren; Duofen He; Yu Han; Laureano D Asico; Pedro A Jose; Chunyu Zeng
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Role of Gα(12)- and Gα(13)-protein subunit linkage of D(3) dopamine receptors in the natriuretic effect of D(3) dopamine receptor in kidney.

Authors:  Ye Zhang; Chunjiang Fu; Laureano D Asico; Van Anthony M Villar; Hongmei Ren; Duofen He; Zhen Wang; Jian Yang; Pedro A Jose; Chunyu Zeng
Journal:  Hypertens Res       Date:  2011-06-02       Impact factor: 3.872

3.  Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats.

Authors:  Jian Yang; Caiyu Chen; Hongmei Ren; Yu Han; Duofen He; Lin Zhou; Ulrich Hopfer; Pedro A Jose; Chunyu Zeng
Journal:  J Hypertens       Date:  2012-06       Impact factor: 4.844

4.  MG53-mediated cell membrane repair protects against acute kidney injury.

Authors:  Pu Duann; Haichang Li; Peihui Lin; Tao Tan; Zhen Wang; Ken Chen; Xinyu Zhou; Kristyn Gumpper; Hua Zhu; Thomas Ludwig; Peter J Mohler; Brad Rovin; William T Abraham; Chunyu Zeng; Jianjie Ma
Journal:  Sci Transl Med       Date:  2015-03-18       Impact factor: 17.956

5.  Oxidative stress and alpha1-adrenoceptor-mediated stimulation of the Cl-/HCO3- exchanger in immortalized SHR proximal tubular epithelial cells.

Authors:  S Simão; S Fraga; P A Jose; P Soares-da-Silva
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

6.  Inhibition of D4 Dopamine Receptors on Insulin Receptor Expression and Effect in Renal Proximal Tubule Cells.

Authors:  Ye Zhang; Hongmei Ren; Xi Lu; Duofen He; Yu Han; Hongyong Wang; Chunyu Zeng; Weibin Shi
Journal:  J Am Heart Assoc       Date:  2016-04-22       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.